x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




SPC questions referred to CJEU in Actavis v Boehringer

07-11-2013

SPC questions referred to CJEU in Actavis v Boehringer

The UK Patents Court has referred four questions to the Court of Justice of the European Union (CJEU) seeking clarification on how the Supplementary Protection Certificate (SPC) Regulation should be interpreted in relation to drug products made of a combination of active ingredients.


SPC, CJEU, Actavis, Boehringer Ingelheim, MicardisPlus

WIPR

Payment types accepted